Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Seattle WA, Sacramento CA, Oakland CA, San Francisco CA,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
for
Lupus Erythematosus, Systemic
Location: Seattle WA, San Francisco CA, St Louis MO, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06897930
Phase 1, Phase 2, Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Seattle WA, Portland OR, Springfield OR, Boise ID,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase 3, Recruiting
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for
Von Willebrand Disease (VWD)
Location: Seattle WA, Sacramento CA, San Francisco CA,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 70+
Code: NCT07115004
Phase 3, Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
for
Hemophilia A
Location: Seattle WA, Orange CA, Aurora CO, Minneapolis MN,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 12+
Code: NCT07416604
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Von Willebrand Factor in Pregnancy (VIP) Study
for
Von Willebrand Diseases
Location: Seattle WA, Salt Lake City UT, Aurora CO, Peoria IL,
Sponsor: University of Washington
Sex: Female
Age: 18+
Code: NCT04146376
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
for
Hemophilia A, Hemophilia B
Location: Seattle WA, Edmonton, Hamilton, Philadelphia PA,
Sponsor: Pfizer
Sex: Male
Age: 1 - 70+
Code: NCT05145127
Phase 3, Recruiting
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
for
Von Willebrand Diseases
Location: Seattle WA, Sacramento CA, Los Angeles CA, Aurora CO,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 60
Code: NCT05776069
Phase 1, Phase 2, Recruiting
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
for
Hemophilia A
Location: Seattle WA, San Diego CA, San Antonio TX
Sponsor: Washington Institute for Coagulation
Sex: Male
Age: 16+
Code: NCT04131036
Recruiting
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
for
Hemophilia A, Hemophilia B
Location: Seattle WA, Rancho Cordova CA, Sacramento CA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT05568719
Phase 3, Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
for
Systemic Lupus Erythematosus,
Location: Seattle WA, Aurora CO, Scottsdale AZ, Rochester MN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06570798
Phase 2, Recruiting
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
for
Von Willebrand Disease (VWD),
Location: Seattle WA, Portland OR, Los Angeles CA, Phoenix AZ,
Sponsor: Hemab ApS
Sex: All
Age: 16+
Code: NCT06610201
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Seattle WA, San Francisco CA, La Jolla CA, Lincoln NE,
Sponsor: Zydus Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07023835
Phase 2, Recruiting
Ultrasound-Guided Obturator Nerve Block for Ambulatory Hip Arthroscopy
for
Pain
Location: Seattle WA
Sponsor: Benaroya Research Institute
Sex: All
Age: 18 - 65
Code: NCT02346357
Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
for
Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Location: Seattle WA, Medford OR, Encino CA, Westminster CA,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 40 - 70+
Code: NCT07725939
Phase 2, Recruiting
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
for
Contraception
Location: Seattle WA, Portland OR, Salt Lake City UT, San Jose CA,
Sponsor: University of Utah
Sex: Female
Age: 16 - 35
Code: NCT05444582
Recruiting
Promoting Optimal Parenting (Bright Start)
for
Cognitive Development, Emotional Development
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: Female
Age: 18 - 23
Code: NCT01573793
Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma